Medical Technology - France

  • France
  • In France, the revenue in the Medical Technology market market is estimated to reach US$20.78bn in 2024.
  • Among the various markets within the market, Medical Devices hold the largest share with a projected market volume of US$17.89bn in the same year.
  • Looking ahead, the revenue is expected to exhibit an annual growth rate of 3.30% (CAGR 2024-2028), leading to a market volume of US$23.66bn by 2028.
  • However, when compared globally, the United States is anticipated to generate the highest revenue, amounting to US$215.80bn in 2024.
  • This further emphasizes the competitive nature of the Medical Technology market market.
  • France is leading the way in the development of innovative medical technology solutions that are revolutionizing the healthcare industry.

Key regions: United States, Germany, China, Japan, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Medical Technology market in France is experiencing significant growth and development.

Customer preferences:
Customers in France are increasingly demanding advanced medical technology solutions that can improve patient outcomes and enhance the efficiency of healthcare delivery. They are looking for devices and equipment that are user-friendly, cost-effective, and deliver accurate results. There is also a growing demand for telemedicine solutions and wearable devices that enable remote monitoring and personalized healthcare.

Trends in the market:
One major trend in the Medical Technology market in France is the adoption of digital health solutions. Healthcare providers are increasingly using electronic health records, telemedicine platforms, and mobile health applications to improve patient care and streamline healthcare processes. This trend is driven by the need to reduce healthcare costs, improve access to healthcare services, and enhance patient engagement. Another trend is the increasing focus on personalized medicine. Advances in genomics and molecular diagnostics have opened up new possibilities for targeted therapies and precision medicine. There is a growing demand for diagnostic tests and medical devices that can provide personalized treatment options based on an individual's genetic makeup.

Local special circumstances:
France has a well-developed healthcare system with universal healthcare coverage. The government plays a significant role in the regulation and funding of healthcare services, including medical technology. The French government has implemented policies to encourage the adoption of innovative medical technologies and digital health solutions. This includes providing financial incentives for healthcare providers to invest in new technologies and promoting collaboration between industry and academia.

Underlying macroeconomic factors:
The growth of the Medical Technology market in France is also influenced by macroeconomic factors. The country has a stable economy and a high standard of living, which allows for increased healthcare spending. The aging population in France is also driving the demand for medical technology, as older individuals require more healthcare services and treatments. Additionally, the increasing prevalence of chronic diseases such as diabetes and cardiovascular diseases is creating a need for advanced medical devices and therapies. In conclusion, the Medical Technology market in France is experiencing growth and development due to customer preferences for advanced medical technology solutions, the adoption of digital health solutions, the focus on personalized medicine, the local special circumstances of the healthcare system, and underlying macroeconomic factors. The market is expected to continue to expand as healthcare providers and patients increasingly embrace innovative medical technologies and solutions.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)